Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3253-3257

  Nehmé, Alissar ^a,b   Baskaran, Rajasekaran ^b   Aebi, Stefan ^a   Nebel, Daniel Fink Sibylle ^a   Cenni, Bruno ^a   Wang, Jean Y J ^b   Howell, Stephen B ^a   Christen, Randolph D ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HEAT SHOCK PROTEIN; PROTEIN KINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; BASE MISPAIRING; CARBOXY TERMINAL SEQUENCE; CELL LINE; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CISPLATIN; COLORECTAL NEOPLASMS; DNA ADDUCTS; DNA REPAIR; DRUG RESISTANCE; ENZYME INDUCTION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-ABL; TUMOR CELLS, CULTURED;

EID: 0030877559     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kelland, L. R. New platinum antitumor complexes. Crit. Rev. Oncol. Hematol., 15: 191-219, 1993.
2. Eastman, A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2: 275-280, 1990.
3. Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., and Kufe, D. W. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature (Lond.), 376: 785-788, 1995.
4. Sanchez, I., Hughes, R. T., Mayer, B. J., Yee, K., Woodgett, J. R., Avruch, J., Kyriakis, J. M., and Zon, L. I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature (Lond.), 372: 794-798, 1994.
5. Derijard, B., Raingeaud, J., Barrett, T., Wu, I. H., Man, J., Ulevitch, R. J., and Davis, R. J. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science (Washington DC), 207: 682-685, 1995.
6. Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S., and Lim, L. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature (Lond.), 367: 40-46, 1994.
7. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev., 7: 2135-2148, 1993.
8. Gupta, S., Campbell, D., Derijard, B., and Davis, R. J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science (Washington DC), 267: 389-393, 1995.
9. Cavigelli, M., Dolfi, F., Claret, F. X., and Karin, M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J., 14: 5957-5964, 1995.
10. Wang, J. Y. J. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev., 3: 35-43, 1993.
11. Welch, P. J., and Wang, J. Y. J. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell, 75: 779-790, 1993.
12. Baskaran, R., Chiang, G. G., and Wang, J. Y. J. Identification of a binding site in c-Abl tyrosine kinase for the C-terminal repeated domain of RNA polymerase II. Mol. Cell. Biol., 16: 3361-3369, 1996.
13. Kolodner, R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev., 10: 1433-1442, 1996.
14. Huddart, R. A., Wooster, R., Horwich, A., and Cooper, C. S. Microsatellite instability in human testicular germ cell tumours. Br. J. Cancer, 72: 642-645, 1995.
15. King, B. L., Carcangiu, M. L., Carter, D., Kiechle, M., Pfisterer, J., Pfleiderer, A., and Kacinski, B. M. Microsatellite instability in ovarian neoplasms. Br. J. Cancer, 72: 376-382, 1995.
16. Fishel, R., and Wilson, T. MutS homologs in mammalian cells. Curr. Opin. Genet. Dev., 7: 105-113, 1997.
17. Drummond, J. T., Anthoney, A., Brown, R., and Modrich, P. Cisplatin and Adriamycin resistance are associated with MutL and mismatch repair deficiency in an ovarian tumor cell line. J. Biol. Chem., 271: 19645-19648, 1996.